Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats

Hypertension

Volumn 27, Issue 2, 1996, Pages 235-244

  Fitzgibbon, Wayne R ^a   Jaffa, Ayad A ^a   Mayfield, Ronald K ^a,b   Ploth, David W ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

angiotensin converting enzyme inhibitors; bradykinin; enalapril; hypertension, renovascular; kinins; vasodilation

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 5,8 [3 (2 THIENYL)ALANINE] 7 DEXTRO PHENYLALANINE]; ENALAPRIL MALEATE; KININ; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; URINARY EXCRETION;

EID: 0030067143     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.2.235     Document Type: Article

References (39)

1. Erdos EG. Angiotensin I converting enzyme. Circ Res. 1975;36:247-255.
2. Ishida H, Scicli AG, Carretero OA. Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins. Hypertension. 1989;14:322-327.
3. Ura N, Carretero OA, Erdos EG. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int. 1987;32:507-513.
4. Verma PS, Gagnon JA, Miller RL. Intrarenal kallikrein-kinin activity in acute renovascular hypertension in dogs. Renal Physiol. 1987;10:311-317.
5. Campbell DJ, Kladis A, Duncan A-M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994;23:439-449.
6. Johnston CI, Clappison BH, Anderson WP, Yasujima M. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol. 1982;49:1401-1404.
7. Roman RJ, Kaldunski ML, Scicli AG, Carretero OA. Influence of kinins and angiotensin II on the regulation of papillary blood flow. Am J Physiol. 1988;255:F690-F698.
8. Fenoy FJ, Scicli G, Carretero O, Roman RJ. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension. 1991;17:1038-1044.
9. Mattson DL, Roman RJ. Role of kinins and angiotensin in the renal hemodynamic response to captopril. Am J physiol. 1991;260:F670-F679.
10. Kon V, Fogo A, Ichikawa I. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int. 1993;44:545-550.
11. Zimmerman BO, Raich PC, Vavrek RJ, Stewart JM. Bradykinin contribution to renal blood How effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog. Circ Res. 1990;66:242-248.
12. Hajj-ali AF, Zimmerman BG. Kinin contribution to renal vasodilator effect of captopril in rabbit. Hypertension. 1991;17:504-509.
13. Hajj-ali AF, Zimmerman BG. Enhanced blood pressure and renal hemodynamic effect of chronic verses acute lisinopril administration in the rabbit. J Pharmacol Exp Ther. 1992;263:158-162.
14. Chen K, Zimmerman BG. Comparison of renal hemodynamic effect of ramiprilat to captopril: possible role of kinins. J Pharmacol Exp Ther. 1994;270:491-497.
15. Komers R, Cooper ME. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins. Am J Physiol. 1995;268:F588-F594.
16. Ploth DW. Angiotensin-dependent renal mechanisms in two-kidney, one-clip renal vascular hypertension. Am J Physiol. 1983;245:F131-F141.
17. El-Dahr SS, Dipp S, Guan S, Navar LG. Renin, angiotensinogen, and kallikrein gene expression in two-kidney Goldblatt hypertensive rats. Am J Hypertens. 1993:6:914-919.
18. Von Thun AM, El-Dahr SS, Vari RC, Navar LG. Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension. Hypertension. 1994;23(suppl I):I-131-I-136.
19. Girolami JP, Praddaude F, Ader JL, Tran Van T, Eche JP, Suc JM. Bilateral urinary kallikrein excretion in the Goldblatt hypertensive rat. Ear Heart J. 1983;4:67-72.
20. 2:-kinin-binding sites in two-kidney, one-clip hypertensive rats. Am J Physiol. 1991;260:F626-F634.
21. Benetos A, Gavras H, Stewart JM, Vavrek RJ, Hatinoglou S, Gavras I. Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension. 1986;8:971-974.
22. Carbonell LF, Carretero OA, Stewart JM, Scicli AG. Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension. 1988;11:239-243.
23. Danckwardt L, Shimizu I, Bonner G, Rettig R, Unger T. Converting enzyme inhibition in kinin-deficient Brown Norway rats. Hypertension. 1990;16:429-435.
24. Bao G, Gohlke P, Unger T. Kinin contribution to chronic antihypertensive actions of ACE-inhibitors in hypertensive rats. In: Bonner G, Fritz H, Schölkens B, Dietze G, Luppertz K, eds. Agents and Actions, Volume 38/II: Recent Progress on Kinins. Berlin, FRG: Birkhäuser Verlag; 1992;38:423-430.
25. Fuhr J, Kaczmarczyk J, Kruttgen CD. Eine einfache colorimetrische methode zur inulin-bestimmung fur nieren-clearance-untersuchungen bei stoffwecksel-gesunden und diabetiken. Klin Wochenschr. 1955;33:729-730.
26. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Grabor M. Renal clearances of substituted hippuric acid derivatives and other aromatic acids in don and man. J Clin Invest. 1945;24:388-404.
27. Jaffa AA, Vio CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF, Mayfield RK. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest. 1992:89:1460-1468.
28. Benetos A, Gavras I, Gavras H. Hypertensive effect of a bradykinin antagonist in normotensive rats. Hypertension. 1986;8:1089-1092.
29. Carbonell LF, Carretero OA, Madeddu P, Scicli AG. Effects of a kinin antagonist on mean blood pressure. Hypertension. 1988;11(suppl I):I-84-I-88.
30. Cachofeiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension. 1992;19:138-145.
31. Madeddu P, Glorioso N, Soro A, Manunta P, Troffa C, Tonolo G, Melis MG, Pazzola A. Effect of a kinin antagonist on renal function and hemodynamics during alterations in sodium balance in conscious normotensive rats. Clin Sci. 1990;78:165-168.
32. Tomiyama H, Scicli AG, Scicli GM, Carretero OA. Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt-treated rats. Hypertension. 1990;15:761-766.
33. Nakagawa M, Stewart JM, Vavrek, RJ, Nasjletti A. Effects of a kinin antagonist on renal function in rats. Am J Physiol. 1990;258:F643-F648.
34. Sharma JN, Stewart JM, Mohsin SSJ, Katori M, Vavrek R. Influence of a kinin antagonist on acute hypotensive responses induced by bradykinin and captopril in spontaneously hypertensive rats. In: Bönner G, Fritz H, Schölkens B, Dietze G, Luppertz K, eds. Agents and Actions, Volume 38/III: Recent Progress on Kinins. Berlin, FRG: Birkhäuser Verlag; 1992;38:258-269.
35. Heller J, Kramer HJ, Horácek V. The effect of kinin and prostaglandin inhibitors on the renal response to angiotensin-converting enzyme inhibition: a micropuncture study in the dog. Pflugers Arch. 1994;427:219-224.
36. Siragy HM, Jaffa AA, Margolius HS. Stimulation of renal interstitial (RI) bradykinin (BK) by sodium depletion. Hypertension. 1992;20:439. Abstract.
37. Jaffa AA, Le Roith D, Roberts CT Jr, Rust PF, Mayfield RK. Insulin-like growth factor 1 produces renal hyperfiltration by a kinin-mediated process. Am J Physiol. 1994;266:F102-F107.
38. Jaffa AA, Rust PF, Mayfield RK. Kinin, a mediator of diabetes-induced glomerular hyperfiltration. Diabetes. 1995;44:156-160.
39. Guan S, Fox J, Mitchell KD, Navar LG. Angiotensin and ACE tissue levels in 2-kidney, 1 clip hypertensive rats. Hypertension. 1992;20:763-767.